Anteilseigner
Cormorant Asset Management LP (19,30 %) Point72 Asset Management LP (6,69 %) Ikarian Capital LLC (5,33 %) The Vanguard Group, Inc. (4,13 %) Adage Capital Management LP (3,95 %) Octagon Capital Advisors LP (3,86 %) Citadel Advisors LLC (3,52 %) Janus Henderson Investors US LLC (3,23 %) Millennium Management LLC (3,10 %) Assenagon Asset Management SA (Germany) (2,47 %) BlackRock Fund Advisors (2,07 %) ETF Managers Group LLC (1,97 %) T. Rowe Price Associates, Inc. (Investment Management) (1,83 %) Barclays Bank Plc (Private Banking) (1,76 %) Morgan Stanley & Co. LLC (1,64 %) Boothbay Fund Management LLC (1,49 %) Walleye Capital LLC (1,26 %) Schonfeld Strategic Advisors LLC (1,18 %) Geode Capital Management LLC (1,04 %) Goldman Sachs & Co. LLC (Private Banking) (1,01 %)
Kontakt
Corbus Pharmaceuticals Holdings Inc